Engineering and Development of VP4-VP7 Rotavirus Fusion Protein in Pichia pastoris

Introduction: Vaccination is the most effective measure to prevent Rotavirus infection in children under five years of age. The most important targets of neutralizing and protective antibodies against this virus are VP4 and VP7 proteins of Rotavirus. Today, the recombinant protein produced in yeast...

Full description

Bibliographic Details
Main Authors: Mostafa Amopour Bahnamiry, Hooman Kaghazian, Seyed Dawood Mousavi-Nasab, Mohammad Reza Aghasadeghi, Golnaz Bahramali
Format: Article
Language:English
Published: Pasteur Institute of Iran 2020-12-01
Series:Vaccine Research
Subjects:
Online Access:http://vacres.pasteur.ac.ir/article-1-263-en.pdf
_version_ 1818049161059106816
author Mostafa Amopour Bahnamiry
Hooman Kaghazian
Seyed Dawood Mousavi-Nasab
Mohammad Reza Aghasadeghi
Golnaz Bahramali
author_facet Mostafa Amopour Bahnamiry
Hooman Kaghazian
Seyed Dawood Mousavi-Nasab
Mohammad Reza Aghasadeghi
Golnaz Bahramali
author_sort Mostafa Amopour Bahnamiry
collection DOAJ
description Introduction: Vaccination is the most effective measure to prevent Rotavirus infection in children under five years of age. The most important targets of neutralizing and protective antibodies against this virus are VP4 and VP7 proteins of Rotavirus. Today, the recombinant protein produced in yeast plays an important role in producing highly effective and cost-effective vaccines. Methods: The effect of different linkers, including flexible and rigid, were evaluated on the stability and immunogenicity of the protein via in silico assays. A suitable linker was selected and expressed in Pichia pastoris yeast. Prediction and validation were carried out using bioinformatics tools, including Expasy's ProtPara, Phyre2 online server, I-TASSER server, ElliPro. Moreover, an appropriate linker was selected for cloning into pPICZα and expression in P. pastoris. Results: The results showed that as a flexible linker, (GGGGS)3 was the best structure to provide stability for VP4-VP7 target fusion protein. The produced recombinant protein was stable after the expression. Conclusion: These in silico results and expression data on P. pastoris suggested that VP4–(GGGGS)3-VP7 construct can potentially serve as a potent immunogenic candidate for recombinant Rotavirus vaccines.
first_indexed 2024-12-10T10:33:10Z
format Article
id doaj.art-15ff5b1d85684d6abed053a1353a4eea
institution Directory Open Access Journal
issn 2383-2819
2423-4923
language English
last_indexed 2024-12-10T10:33:10Z
publishDate 2020-12-01
publisher Pasteur Institute of Iran
record_format Article
series Vaccine Research
spelling doaj.art-15ff5b1d85684d6abed053a1353a4eea2022-12-22T01:52:30ZengPasteur Institute of IranVaccine Research2383-28192423-49232020-12-017210110610.52547/vacres.7.2.101Engineering and Development of VP4-VP7 Rotavirus Fusion Protein in Pichia pastorisMostafa Amopour Bahnamiry0https://orcid.org/0000-0002-0542-4000Hooman Kaghazian1https://orcid.org/0000-0003-4301-3381Seyed Dawood Mousavi-Nasab2https://orcid.org/0000-0002-4831-3108Mohammad Reza Aghasadeghi3https://orcid.org/0000-0003-2186-0774Golnaz Bahramali https://orcid.org/0000-0002-1762-4907Department of Research and Development, Production and Research Complex, Pasteur Institute of Iran, Tehran, IranDepartment of Research and Development, Production and Research Complex, Pasteur Institute of Iran, Tehran, IranViral Vaccine Research Center, Pasteur Institute of Iran, Tehran, Iran Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran. Introduction: Vaccination is the most effective measure to prevent Rotavirus infection in children under five years of age. The most important targets of neutralizing and protective antibodies against this virus are VP4 and VP7 proteins of Rotavirus. Today, the recombinant protein produced in yeast plays an important role in producing highly effective and cost-effective vaccines. Methods: The effect of different linkers, including flexible and rigid, were evaluated on the stability and immunogenicity of the protein via in silico assays. A suitable linker was selected and expressed in Pichia pastoris yeast. Prediction and validation were carried out using bioinformatics tools, including Expasy's ProtPara, Phyre2 online server, I-TASSER server, ElliPro. Moreover, an appropriate linker was selected for cloning into pPICZα and expression in P. pastoris. Results: The results showed that as a flexible linker, (GGGGS)3 was the best structure to provide stability for VP4-VP7 target fusion protein. The produced recombinant protein was stable after the expression. Conclusion: These in silico results and expression data on P. pastoris suggested that VP4–(GGGGS)3-VP7 construct can potentially serve as a potent immunogenic candidate for recombinant Rotavirus vaccines.http://vacres.pasteur.ac.ir/article-1-263-en.pdfrotavirusvaccinebioinformaticppiczαpichia pastoris
spellingShingle Mostafa Amopour Bahnamiry
Hooman Kaghazian
Seyed Dawood Mousavi-Nasab
Mohammad Reza Aghasadeghi
Golnaz Bahramali
Engineering and Development of VP4-VP7 Rotavirus Fusion Protein in Pichia pastoris
Vaccine Research
rotavirus
vaccine
bioinformatic
ppiczα
pichia pastoris
title Engineering and Development of VP4-VP7 Rotavirus Fusion Protein in Pichia pastoris
title_full Engineering and Development of VP4-VP7 Rotavirus Fusion Protein in Pichia pastoris
title_fullStr Engineering and Development of VP4-VP7 Rotavirus Fusion Protein in Pichia pastoris
title_full_unstemmed Engineering and Development of VP4-VP7 Rotavirus Fusion Protein in Pichia pastoris
title_short Engineering and Development of VP4-VP7 Rotavirus Fusion Protein in Pichia pastoris
title_sort engineering and development of vp4 vp7 rotavirus fusion protein in pichia pastoris
topic rotavirus
vaccine
bioinformatic
ppiczα
pichia pastoris
url http://vacres.pasteur.ac.ir/article-1-263-en.pdf
work_keys_str_mv AT mostafaamopourbahnamiry engineeringanddevelopmentofvp4vp7rotavirusfusionproteininpichiapastoris
AT hoomankaghazian engineeringanddevelopmentofvp4vp7rotavirusfusionproteininpichiapastoris
AT seyeddawoodmousavinasab engineeringanddevelopmentofvp4vp7rotavirusfusionproteininpichiapastoris
AT mohammadrezaaghasadeghi engineeringanddevelopmentofvp4vp7rotavirusfusionproteininpichiapastoris
AT golnazbahramali engineeringanddevelopmentofvp4vp7rotavirusfusionproteininpichiapastoris